Literature DB >> 28264950

Direct-To-Consumer Telehealth May Increase Access To Care But Does Not Decrease Spending.

J Scott Ashwood1, Ateev Mehrotra2, David Cowling3, Lori Uscher-Pines4.   

Abstract

The use of direct-to-consumer telehealth, in which a patient has access to a physician via telephone or videoconferencing, is growing rapidly. A key attraction of this type of telehealth for health plans and employers is the potential savings involved in replacing physician office and emergency department visits with less expensive virtual visits. However, increased convenience may tap into unmet demand for health care, and new utilization may increase overall health care spending. We used commercial claims data on over 300,000 patients from three years (2011-13) to explore patterns of utilization and spending for acute respiratory illnesses. We estimated that 12 percent of direct-to-consumer telehealth visits replaced visits to other providers, and 88 percent represented new utilization. Net annual spending on acute respiratory illness increased $45 per telehealth user. Direct-to-consumer telehealth may increase access by making care more convenient for certain patients, but it may also increase utilization and health care spending. Project HOPE—The People-to-People Health Foundation, Inc.

Entities:  

Keywords:  Access To Care; Cost of Health Care; Health Spending; Organization and Delivery of Care

Mesh:

Year:  2017        PMID: 28264950     DOI: 10.1377/hlthaff.2016.1130

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  48 in total

Review 1.  Teleneurology and mobile technologies: the future of neurological care.

Authors:  E Ray Dorsey; Alistair M Glidden; Melissa R Holloway; Gretchen L Birbeck; Lee H Schwamm
Journal:  Nat Rev Neurol       Date:  2018-04-06       Impact factor: 42.937

Review 2.  Telemedicine in Complex Diabetes Management.

Authors:  Marie E McDonnell
Journal:  Curr Diab Rep       Date:  2018-05-24       Impact factor: 4.810

3.  Antibiotic Prescribing During Pediatric Direct-to-Consumer Telemedicine Visits.

Authors:  Kristin N Ray; Zhuo Shi; Courtney A Gidengil; Sabrina J Poon; Lori Uscher-Pines; Ateev Mehrotra
Journal:  Pediatrics       Date:  2019-04-08       Impact factor: 7.124

4.  Patterns of Use and Correlates of Patient Satisfaction with a Large Nationwide Direct to Consumer Telemedicine Service.

Authors:  Kathryn A Martinez; Mark Rood; Nikhyl Jhangiani; Lei Kou; Susannah Rose; Adrienne Boissy; Michael B Rothberg
Journal:  J Gen Intern Med       Date:  2018-08-15       Impact factor: 5.128

5.  Trends in Visits to Acute Care Venues for Treatment of Low-Acuity Conditions in the United States From 2008 to 2015.

Authors:  Sabrina J Poon; Jeremiah D Schuur; Ateev Mehrotra
Journal:  JAMA Intern Med       Date:  2018-10-01       Impact factor: 21.873

6.  Patients' preferences over care settings for minor illnesses and injuries.

Authors:  Dana B Mukamel; Heather Ladd; Alpesh Amin; Dara H Sorkin
Journal:  Health Serv Res       Date:  2019-04-29       Impact factor: 3.402

7.  Use of Commercial Direct-to-Consumer Telemedicine by Children.

Authors:  Kristin N Ray; Zhuo Shi; Sabrina J Poon; Lori Uscher-Pines; Ateev Mehrotra
Journal:  Acad Pediatr       Date:  2019-01-10       Impact factor: 3.107

8.  Value of Telemonitoring and Telemedicine in Heart Failure Management.

Authors:  Gian Franco Gensini; Camilla Alderighi; Raffaele Rasoini; Marco Mazzanti; Giancarlo Casolo
Journal:  Card Fail Rev       Date:  2017-11

9.  Direct-To-Consumer Telemedicine Visits For Acute Respiratory Infections Linked To More Downstream Visits.

Authors:  Kathleen Yinran Li; Ziwei Zhu; Sophia Ng; Chad Ellimoottil
Journal:  Health Aff (Millwood)       Date:  2021-04       Impact factor: 6.301

10.  Telemedicine consultations with physicians in Swedish primary care: a mixed methods study of users' experiences and care patterns.

Authors:  Felicia Gabrielsson-Järhult; Sofia Kjellström; Kristina Areskoug Josefsson
Journal:  Scand J Prim Health Care       Date:  2021-05-11       Impact factor: 2.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.